Ondansetron
NDC 85534-0063, Ondansetron, tablet, orally disintegrating, from HAWAII REPACK, INC..
- Product NDC
- 85534-0063
- Status
- Listed
- Labeler
- HAWAII REPACK, INC.
- Dosage form
- TABLET, ORALLY DISINTEGRATING
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA090469
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/85534-0063 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ONDANSETRON8 mg/1
Pharmacologic classes
Serotonin 3 Receptor Antagonists [MoA]; Serotonin-3 Receptor Antagonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 85534-0063-0 | 85534006300 | 10 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (85534-0063-0) |
| 85534-0063-1 | 85534006301 | 20 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (85534-0063-1) |
| 85534-0063-2 | 85534006302 | 30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (85534-0063-2) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/b76c5cc9-f1ca-428b-8989-36a66802b650
Use it
Look up 85534-0063 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/85534-0063 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 85534-0063. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.